Agilus Diagnostics Ltd

Agilus Diagnostics, founded in 1995, has built nearly three decades of expertise, trust, and innovation in the Indian diagnostics sector. Utilizing a strategic hub-and-spoke model, the company seamlessly collects specimens from multiple locations and centralizes testing in its reference laboratories. In fiscal year 2023 alone, Agilus served over 16.6 million patients with an average of more than 107,000 diagnostic tests conducted daily.

Agilus boasts a vast network that includes a global reference lab, five regional labs, three Centers of Excellence, radiology and wellness centers, as well as more than 40 labs accredited by NABL and CAP. Its test menu spans over 3,800 options, ranging from routine pathology tests to advanced molecular diagnostics, genomics, reproductive medicine, rare diseases, and inherited disorder analysis, along with radiology including ultrasound, X-ray, MRI, and CT scans.

Agilus prioritizes customer-centric innovation through streamlined technology and efficient logistics. These include route optimization, barcode-based registration, integrated billing and reporting systems—all designed to reduce errors and accelerate turnaround times to elevate the overall patient experience. Backed by Fortis Healthcare’s legacy and robust management strength, Agilus continues to advance diagnostics and strengthen its reputation among patients, medical professionals, and healthcare providers.